Close

Aurinia Pharmaceuticals (AUPH) Misses Q3 EPS by 7c; Initiates Talks with Japan for Voclosporin Phase 1

Go back to Aurinia Pharmaceuticals (AUPH) Misses Q3 EPS by 7c; Initiates Talks with Japan for Voclosporin Phase 1
(NASDAQ: AUPH) Delayed: 5.01 +0.01 (0.20%)
Previous Close $5.00    52 Week High $5.69 
Open $4.99    52 Week Low $1.42 
Day High $5.03    P/E N/A 
Day Low $4.97    EPS $0.00 
Volume 1,375,006